Products & Services
Aura Pharm forecasts an initial annual production of 1,2 tons (1,200 kilograms) of cannabis dry flowers, with a mid-term goal of increasing production to1,5 tones (1,500 kilograms) of cannabis dry flowers.
For the planned production of pharmaceutical-grade cannabis extracts, Aura Pharm intends to utilize raw materials sourced from its own cultivation of medical cannabis plants. This extraction process will involve the full extraction of high-quality cannabinoids and terpenes to create potent and pure, highly concentrated cannabis oil with specific cannabinoids and a unique terpene profile.
For the planned production of pharmaceutical-grade cannabis extracts, Aura Pharm intends to utilize raw materials sourced from its own cultivation of medical cannabis plants. This extraction process will involve the full extraction of high-quality cannabinoids and terpenes to create potent and pure highly concentrated cannabis oil with specific cannabinoids and unique terpene profile.
By producing these concentrates with standardized techniques, in GMP regulated production, quality control testing in every step of the production, Aura Pharm aims to maintain full control over the quality of cannabis oil products, thereby ensuring the delivery of reliable, high-quality products to the customers.
